24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial.

24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial.

The optimal treatment of hepatitis C virus (HCV) genotype 6 is unclear owing to its limited geographic distribution. Because of a high predictive value of rapid virological response (RVR) for sustained virological response (SVR), we conducted an open-label randomized controlled trial to compare 24-...

Full description

Bibliographic Details
Main Authors: Qingxian Cai, Xiaohong Zhang, Chaoshuang Lin, Xiaoqiong Shao, Yujuan Guan, Hong Deng, Min Wei, Mingshou Huang, Zefang Ren, Ling Lu, Yongyu Mei, Min Xu, Jianyun Zhu, Haiyan Shi, Guoli Lin, Ying Liu, Fengyu Hu, Qiumin Luo, Yun Lan, Fengxia Guo, Zhixin Zhao, Zhiliang Gao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4624894?pdf=render

Internet

http://europepmc.org/articles/PMC4624894?pdf=render

Similar Items